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Edited by Vladimir SkulachevAbstract Photodynamic treatment (PDT) employs a photosen-
sitizer and the light-induced formation of reactive oxygen species
– antagonized by cellular antioxidant systems – for the removal
of harmful cells. This study addresses the eﬀect of altered carbo-
hydrate metabolism on the cellular antioxidant glutathione sys-
tem, and the subsequent responses to PDT. It is shown that
glucose-deprivation of 18 h prior to PDT causes a reduced level
of intracellular glutathione and an increased cytotoxicity of
PDT. These eﬀects can be mimicked by inhibitors of glutathione
synthesis (buthionine-sulfoximine) or its regeneration (1,3-bis-(2-
chlorethyl)-1-nitrosourea). Inhibited glutathione metabolism
shifts the apoptotic window to lower ﬂuences, while glucose
deprivation abolishes apoptosis as a result of ATP deﬁciency.
Our results prove evidence for manipulation of the outcome of
PDT through internal metabolic pathways.
 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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doi:10.1016/j.febslet.2004.11.073to the cellular integrity since they can oxidize almost every
compound of biological origin and hence can cause severe cel-
lular damage when produced over a certain level of quantity
[1–3]. Photodynamic therapy (PDT) uses massive generation
of ROS in target cells by application of photosensitizing mol-
ecules such as protoporphyrin or phthalocyanine derivatives
and activation of these compounds by irradiation with light
of the appropriate energy for the removal of harmful and un-
wanted cells [4]. By this, both modes of cell death, apoptosis
and necrosis are induced in the target tissue (for review, see
[5,6]).
To a certain extent, photodynamic therapy is antagonized by
cellular antioxidant defense mechanisms. The antioxidative
capacity of reduced glutathione (GSH) is employed to scav-
enge reactive oxygen intermediates yielding oxidized glutathi-
one (GSSG), which can be regenerated to GSH by
glutathione reductase under the expense of nicotine adenine
dinucleotide phosphate reduced (NADPH) [7–9]. Among other
carbohydrates, glucose and its metabolization in the ﬁrst reac-
tions of the pentose phosphate pathway (PPP) represent the
most important source of NADPH [10,11]. From this knowl-
edge, one might hypothesize that the availability of glucose
and its metabolization in the PPP aﬀects the cells capability
to regenerate GSH to the usual millimolar concentration range
[10,12] and subsequently the cellular sensitivity towards PDT.
Besides the consequences of altered carbohydrate metabo-
lism for the supply of NADPH, glucose deprivation (among
other eﬀects, see Section 4) also impairs cellular energetics by
inhibition of glycolytic ATP production. This is of special
importance for the mode of cell death induced by PDT: glyco-
lytic ATP production may partly compensate for mitochon-
drial impairment during apoptosis and supply the ATP-
requiring steps in active cell death [13–15]. We could prove this
hypothesis in a set of experiments published recently, where
glucose deprivation of photosensitized cells in vitro causes a
rapid drop of ATP and subsequently an inhibition of apoptosis
and a shift to necrotic cell death under conditions which nor-
mally would cause apoptosis [16]. An additional eﬀect of im-
paired glycolytic ATP production may consist in reduced de
novo synthesis of GSH, which requires two moles ATP per
mole GSH [7,9].
By taking up these results, we expand the analysis of the ef-
fects of impaired carbohydrate metabolism to the possible
inﬂuence on the antioxidative mechanisms during PDT.
Employing a well established model system consisting of theblished by Elsevier B.V. All rights reserved.
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onate (AlPcS4) and the human epidermoid carcinoma cell line
A431, the present study addresses the question whether an al-
tered carbohydrate metabolism would aﬀect the cellular ROS
antioxidative mechanisms and thus the susceptibility towards
PDT. The increase in sensitivity to ROS caused by conditions
of glucose deprivation could be causally attributed to impaired
GSH regeneration or synthesis. However, as shown in this
study, artiﬁcial inhibition of GSH metabolism did not inﬂu-
ence the cells ability to undergo apoptosis (in contrast to glu-
cose-free conditions).
Aware of the fact that PDT is applied clinically in several
countries for treatment of malignant and non-malignant dis-
eases [4], this study proves the importance of the cellular (car-
bohydrate) metabolism for inﬂuencing the cellular
susceptibility towards PDT and, therefore, the eﬃciency of
the treatment regime.2. Materials and methods
2.1. Cell culture and photodynamic treatment
A431 human epidermoid carcinoma cells (ATCC-Nr. CRL-1555)
were cultured in Dulbeccos modiﬁed Eagles Medium (DMEM;
Sigma–Aldrich, Vienna, Austria) containing 4.5 g l1 glucose supple-
mented with 10 mM HEPES, 4 mM L-glutamine, 1 mM Na-pyruvate,
100 U ml1 penicillin, 0.1 mg ml1 streptomycin and 5% fetal calf ser-
um (FCS) (all from PAA-laboratories, Linz, Austria), in a humidiﬁed
atmosphere at 37 C and 7.5% CO2. For measurement of caspase-3 like
activity, nuclear fragmentation and ROS production, 3 · 105 cells were
seeded into 30 mm petri dishes (Greiner Bio-One, Kremsmuenster,
Austria); for measurement of cytotoxicity, 7500 and 12500 cells were
seeded into 96-well microplates (black walls, clear bottom; Greiner
Bio-One) for samples cultured with or without glucose, respectively.
Eighteen hours prior to PDT (i.e., 24 h after seeding the cells, in the
log phase), the medium was replaced with 0% FCS DMEM (standard
conditions, further referred to as DMEM) or – after a washing step
with phosphate buﬀered saline (PBS) – with glucose-free Dulbeccos
modiﬁed Eagles Medium base (0% FCS, further referred to as GF-
DMEM; Sigma–Aldrich) supplemented as above containing 10 lM
AlPcS4 (product no. AlPcS-834; Frontier Scientiﬁc/Porphyrin Prod-
ucts, Logan, USA). When indicated, 3 mM DL-buthionine-sulfoximine
(BSO; Fluka, Buchs, Switzerland) was added simultaneously with the
sensitizer (18 h) and 500 lM 1,3-bis(2-chloroethyl)-1-nitrosourea
(BCNU, Sigma–Aldrich) was added 1 h prior to irradiation.
Immediately before irradiation, the culture supernatant was replaced
by fresh 0% FCS medium (DMEM or GF-DMEM). Irradiation was
performed using a red-light illumination diode array (kmax = 660 ± 20
nm, super bright diodes, product no. L53SRC-F from Kingbright
Electronic, Issum, Germany) with a light power of 10 mW cm2. Sam-
ples were protected from ambient light; for all experiments cells from
passage number 5–15 were used.2.2. Cytotoxicity
Metabolic/mitochondrial activity was assessed by the reduction
of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide
(MTT) to the insoluble blue formazan catalyzed by mitochondrial and
other cellular dehydrogenases [17]. For this purpose, cells were incu-
bated for 23 hours after irradiation and the medium was replaced by
100 ll of DMEM for all samples to restore the carbohydrate metabo-
lism of the cells kept in glucose-free medium, which has been proven in
preliminary experiments (data not shown) to allow suﬃcient conver-
sion of MTT. After another hour, 10 ll of a solution containing
MTT (5 mg ml1 in PBS) was added to the microplate wells. Reduc-
tion of MTT was allowed to proceed for 45 min; afterwards the med-
ium was removed, the formazan dye was solubilized by addition of 100
ll 2-propanol and the absorbance was measured at 565 nm using a
Spectraﬂuor microplate reader (Tecan, Salzburg, Austria).2.3. Measurement of intracellular glutathione
Intracellular GSH was extracted and measured based on a protocol
published by Griﬃth [18]. In short, cells were cultured in 60 mm petri
dishes (7.5 · 105 cells/3 ml medium) under conditions described above
(DMEM, BSO, BCNU, GF-DMEM; all without sensitizer). At that
time where the samples are – otherwise – PDT-treated, the supernatant
was removed, the cells were washed twice with PBS and harvested by
trypsinization. Dilution series of the cell samples as well as of GSH
(Sigma–Aldrich) were made in PBS and extracted with 1 volume 5-sul-
fosalicylic acid (5%, w/v); cell debris was removed by centrifugation
and the GSH released from the cells was measured by addition of 5-
5 0-dithio-bis(2-nitrobenzoic acid) (Ellmans reagent, absorbance at
405 nm; Spectraﬂuor reader, Tecan). From estimation of the cell diam-
eter and cell number by means of an electronic cell counter (CASY-1,
Schaerfe-Systems, Reutlingen, Germany; usually in the range of 19
lm), the intracellular concentration of GSH, [GSH]ic, was calculated.
2.4. Measurement of intracellular ROS
The measurement of intracellular ROS is based on the oxidation of
DCFH-DA (2 0,7 0-dichlorodihydroﬂuorescein diacetate), which is
quantiﬁed by ﬂow cytometry [1]. In brief, 30 min prior to irradiation,
cells (treated with BSO/BCNU or GF-DMEM as described above)
were incubated with 50 lM DCFH-DA. Twenty minutes after irradi-
ation, cells including the supernatant were harvested using Accutase
(PAA-laboratories); all subsequent steps were performed on ice. The
cells were spun down at 840 ·g and washed once with PBS; after an-
other centrifugation step, the pellet was resuspended in 500 ll PBS
and the resulting red ﬂuorescing DCF (2 0–7 0-dichloroﬂuorescein) was
analyzed by ﬂow cytometry (FACS Calibur, Beckton–Dickinson,
Franklin Lakes, NJ, USA). For each sample, 10000 cells were ana-
lyzed; the ﬂuorescence signal (FL2 channel, kEX = 488 nm,
kEM = 580 ± 40 nm) was evaluated as discussed in Section 3.
2.5. Apoptosis detection (I): caspase-3 assay
As a central indicator of apoptotic cell death, 5 h post-treatment the
activity of caspase-3 like proteases was analyzed by means of a ﬂuori-
genic peptide. For experimental details, see [16]. The results are related
to the protein content to correct for variations in cell number assayed;
ﬁnally, the data are shown as percentage of an UV-treated sample (200
mJ cm2, kmax = 254 nm, Stratagenes Stratalinker, Amsterdam, Neth-
erlands), which is referred to induce a homogenous apoptotic popula-
tion of cells [19].
2.6. Apoptosis detection (II): nuclear fragmentation
Nuclear fragmentation during apoptosis is measured by analysis of
the DNA content. This method is based on the ﬂow cytometric analy-
sis of the DNA histogram of ethanol-ﬁxed, ribonuclease A-treated and
propidium iodide (PI) stained cells, whereby cells characterized by a
smaller ﬂuorescence than the G1 peak were considered as apoptotic
cells (Sub-G1 peak). For the detailed protocol, see [16]; for each sam-
ple, 10000 cells were analyzed.
2.7. Statistical evaluation
Mean values of three independent experiments ± S.E.M. or Gauss-
ian Errors are shown throughout. Statistical signiﬁcance was evaluated
using Students t test.3. Results
3.1. Cellular sensitivity towards PDT and its relationship to
glucose/glutathione metabolism
In order to determine the eﬃciency of the PDT protocol ap-
plied, we employed the MTT assay which gives information on
metabolic/mitochondrial activity and hereby allows an estima-
tion of the overall cytotoxicity [20].
Fig. 1 shows the percentage of the MTT activity of standard
PDT samples (DMEM), cells grown under glucose-free condi-
tions (GF-DMEM) and those treated with inhibitors of the
glutathione metabolism (BSO or BCNU) as related to the
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Fig. 2. Intracellular GSH under diﬀerent metabolic conditions.
Intracellular GSH concentration ([GSH]ic, mM) was measured for
samples with diﬀerent media and additives (3 mM BSO (buthionine
sulfoximine) or glucose-free medium (GF-DMEM) for 18 h and 500
lM BCNU (1,3-bis-(2-chloroethyl)-1-nitrosourea) for 1 h). Mean
values of three independent measurements ± S.E.M. Highly signiﬁcant
(P < 0.01)/signiﬁcant (P < 0.05) diﬀerences compared to the control
sample (DMEM) are indicated by \\ and \, respectively.
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Fig. 1. Survival of photosensitized A431 cells under conditions of impaired carbohydrate/glutathione metabolism. PDT-induced cytotoxicity was
assessed 24 h p.i. by means of MTT assay (Section 2.2). Results are expressed as relative MTT activity of untreated control samples; these controls
(treated with BSO/BCNU/GF-DMEM but without PDT) are shown in the insertion. When indicated (BSO/BCNU), 3 mM buthionine sulfoximine
was added 18 h and 500 lM 1,3-bis-(2-chloroethyl)-1-nitrosourea was added 1 h before illumination, respectively; GF-DMEM indicates glucose free
medium. Mean values from three independent experiments (error bars as calculated by the Gaussian law of error propagation). Highly signiﬁcant
(P < 0.01)/signiﬁcant (P < 0.05) diﬀerences compared to the standard PDT samples (DMEM) are indicated by \\ and \, respectively.
T. Kiesslich et al. / FEBS Letters 579 (2005) 185–190 187respective controls (non-irradiated, without AlPcS4, but simi-
larly treated with GF-DMEM/BSO/BCNU). These controls
showed the following MTT activities: DMEM 100%, BSO
87.3% ± 1.4, BCNU 79.8% ± 1.4 and GF-DMEM 50.1% ±
10.4 (see insertion in Fig. 1). Preceding control experiments
[16] showed that this reduction is not due to cell killing by
the media composition itself, but caused by reduced prolifera-
tion (data not shown). Furthermore, at a concentration of 10
lM, dark controls (data not shown) demonstrated AlPcS4
not to be toxic.
All curves are characterized by a steep decrease in MTT
activity within about a 2 J cm2 change in light ﬂuence ranging
from 90% to 100% MTT activity to about 10% at higher light
doses. Although similarly shaped, the curves for the glucose-
free sample as well as those of cells with impaired GSH metab-
olism are clearly shifted to lower light doses as compared to
the standard PDT treated cells (DMEM): a shift of about 1
J cm2 is found for glucose free samples and those treated with
BSO; a smaller change (approximately 0.5 J cm2) is found for
BCNU treated samples.
3.2. Intracellular GSH
The intracellular concentration of GSH at the time of PDT
is shown in Fig. 2. Treatment with BSO (3 mM, 18 h) reduced
[GSH]ic from 6 mM (DMEM) to 1 mM; in contrast, the GSH
level of cells treated with BCNU was not signiﬁcantly reduced.
The concentration of GSH in samples deprived of glucose for
18 h was nearly reduced to half (3 mM).3.3. Generation of ROS by PDT
Determination of intracellular ROS was employed in order
to clarify whether the altered cellular sensitivity caused by glu-
cose depletion or inhibition of GSH metabolism by BSO or
BCNU is caused by an alteration of ROS generation followingPDT. The level of intracellular ROS is changed even under
control conditions (without PDT, see Fig. 3); for samples trea-
ted with GF-DMEM/BSO/BCNU but without PDT, a DCF
signal for glucose-free samples and those treated with BSO
or BCNU of about 58, 39, and 22 rfu (relative ﬂuorescence
units), respectively, can be found compared to control
(DMEM, 13 rfu).
For PDT, the dynamics of ROS generation in standard PDT
samples (DMEM) is characterized by an increase of intracellu-
lar ROS with a small slope at low light ﬂuences (0.25–1 J cm2)
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Fig. 3. Generation of intracellular ROS by photodynamic treatment.
Intracellular ROS were determined by ﬂow cytometric analysis of
DCFH-DA oxidation (Section 2.4). When indicated (BSO/BCNU), 3
mM buthionine sulfoximine was added 18 h and 500 lM 1,3-bis-(2-
chloroethyl)-1-nitrosourea was added 1 h before illumination, respec-
tively; GF-DMEM indicates glucose free medium. The ﬁrst data points
(0 J cm2) refer to untreated controls (treated with BSO/BCNU/GF-
DMEM but without PDT). Data, given as rfu (relative ﬂuorescence
units), are representative of three independent experiments ± S.E.M.
Highly signiﬁcant (P < 0.01)/signiﬁcant (P < 0.05) diﬀerences com-
pared to the standard PDT samples (DMEM) are indicated by \\
and \, respectively.
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vation of glucose causes a high level of DCFH-DA oxidation
already at low doses, i.e., an increased level of intracellular
ROS is observed within the whole range of PDT doses. Inhibi-
tion of GSH synthesis or reduction by BSO and BCNU,
respectively, results in a gradual elevation of ROS generated
by PDT, although the eﬀect is more pronounced for BSO-trea-
ted samples.
At high light doses (>1.75 J cm2), an additional peak ap-
pears in the DCF histogram which shows considerable lower
ﬂuorescence than the untreated control samples (about 1 order
of magnitude lower; data not shown). These cells were not in-
cluded in the analysis, since this peak contains most probably
necrotic cells characterized by reduced membrane integrity
which caused the ﬂuorescent dye to leak into the medium.
3.4. Induction of apoptosis by PDT and its relationship to
glucose/glutathione metabolism
Fig. 4A shows the activity of caspase-3 like enzymes 5 h p.i.
depending on the light ﬂuence. For standard PDT treated cells,
caspase-3 activation peaked at a ﬂuence of 2 J cm2 (non-irra-
diated controls without sensitizer are indicated by a light dose
of 0 in the diagram). The maxima of caspase-3 like activity of
samples treated with BSO or BCNU are clearly shifted to
lower irradiation doses of about 1.5 J cm2. For glucose-free
cells, no signiﬁcant activation of capase-3 like enzymes can
be found.
Results from determination of the nuclear fragmentation
conﬁrm these ﬁndings: as shown in Fig. 4B, maxima of nuclear
fragmentation are present at 2 and 1.5 J cm2 for standard
PDT samples and cells treated with BSO/BCNU, respectively;
again, impairment of the GSH metabolism results in a shift of
the apoptotic window to lower irradiation doses. In accor-
dance with the results from caspase activation (Fig. 4A), noapoptotic nuclear fragmentation can be found for cells de-
prived of glucose.4. Discussion
Manipulation of the source or metabolization of carbohy-
drates inﬂuences the pathways of cellular energy metabolism
by altering the supply of substrates for glycolysis and the pen-
tose phosphate pathway. By this, changes in the availability of
glycolytic substrates will also aﬀect the cells ability to form
NADPH. The latter represents the crucial coupling agent for
a cellular mechanism involved in antioxidative defense, the
glutathione system, since its regeneration (from GSSG to
GSH, catalyzed by glutathione reductase) is dependent on
reducing power. These facts motivated us to investigate
whether the supply of glucose would inﬂuence the cellular
ROS quenching mechanisms and whether an increase of the
sensitivity towards ROS caused by conditions of glucose depri-
vation can be causally attributed to impaired GSH regenera-
tion or synthesis. For this purpose, two diﬀerent metabolic
inhibitors were used to (i) deplete total glutathione by inhibi-
tion of c-glutamyl-cystein synthase (an ATP-requiring step
within the pathway of GSH de novo synthesis [7,9]; inhibited
by BSO [21]) and (ii) inhibit the regeneration of GSH from
the oxidized form, GSSG (catalyzed by NADPH-dependent
glutathione reductase [7,9]; inhibited by BCNU [22]).
In a ﬁrst set of experiments, the overall cytotoxicity of PDT
under such conditions was analyzed. Both, glucose withdrawal
as well as depletion of cellular glutathione (or inhibition of its
regeneration) resulted in a signiﬁcant increase in cytotoxicity.
These results are consistent with the ﬁndings of Miller et al.
[23] where addition of BSO to several cell lines caused in-
creased cytotoxicity of Photofrin PDT and c irradiation. The
reason why BCNU resulted in a less pronounced cytotoxicity
when compared to BSO may be caused by an incomplete inhi-
bition of glutathione reductase when BCNU was applied as de-
scribed; furthermore (see Fig. 2), at the time of PDT, the
samples treated with BCNU are still provided with about 5
mM intracellular GSH, which is available for an initial
quenching of ROS. Similar results were obtained by another
group who studied the eﬀect of glucose deprivation on the cel-
lular sensitivity towards H2O2 [10]. The striking similarity be-
tween samples withdrawn of glucose as a substrate for the
pentose phosphate cycle and those with hindered GSH metab-
olism give ﬁrst evidence for a causal relationship between the
increased sensitivity of glucose deprived cells and their GSH
metabolism.
This suspected causal relationship of carbohydrate metabo-
lism and the GSH system is supported by measurement of
intracellular GSH (Fig. 2). Two explanations can be given
for the severe reduction of [GSH]ic in glucose-free samples:
(i) ROS generated under conditions of increased respiratory
activity that compensates for an inhibition of glycolytic ATP
production in GF-DMEM samples cause oxidation and reduc-
tion of [GSH]ic which, furthermore, cannot be regenerated due
to a lack of PPP substrates; and (ii) the detrimental eﬀect of
glucose-free conditions on the cellular energy metabolism
and ATP generation results in a reduced rate of the ATP-
requiring de novo synthesis of GSH. It is not clear to which ex-
tent these explanations hold true of the data shown; however,
both apply to the central hypothesis of this study.
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Fig. 4. Apoptosis induced by photodynamic treatment. Photosensi-
tized cells with impaired glucose/glutathione metabolism were analyzed
for caspase activation and nuclear fragmentation. When indicated
(BSO/BCNU), 3 mM buthionine sulfoximine was added 18 h and
500 lM 1,3-bis-(2-chloroethyl)-1-nitrosourea was added 1 h before
illumination, respectively; GF-DMEM indicates glucose free medium.
(A) Activity of caspase-3 like enzymes 5 h p.i. related to UV-treated
cells (a homogenous apoptotic cell population). (B) Nuclear fragmen-
tation (Sub-G1 peak) 8 h p.i. All data are representatives of three
independent experiments ± Gaussian error bars (A) or S.E.M. (B).
T. Kiesslich et al. / FEBS Letters 579 (2005) 185–190 189The results of measurement of cytotoxicity are essentially
strengthened by analysis of PDT-based generation of ROS un-
der identical conditions. PDT applied to cells with impaired
glucose or GSH metabolism results in increased intracellular
ROS levels. When using DCFH-DA for measurement of
ROS, it is important to note that this dye does not measure sin-
glet oxygen itself [24], hence DCFH-DA may only give semi-
quantitative information about ROS generated by PDT but
yet allowing meaningful comparison within a ﬂuence series
of a given PDT treatment. The high ROS signal of GF-
DMEM samples (even without PDT), therefore, could reﬂect
other reactive oxygen species generated by cellular respiration
fuelled by pyruvate [2]. Taken together, the eﬀect of glucose
deprivation/BSO or BCNU treatment on PDT-based genera-
tion of ROS is most obviously indicated by the initial in-
crease/slope of the signal at the transition from 0 to 0.3
J cm2, which is – regardless of the absolute values – more pro-nounced for all samples compared to the standard DMEM
sample. We have previously shown [16] that massive necrosis
occurs under glucose-free conditions at higher light ﬂuences;
this is the reason why the ROS signal for GF-DMEM samples
even decrease at higher PDT doses, since the dye is most prob-
ably released from necrotic cells.
Based on these results, we further analyzed the eﬀect of im-
paired glutathione metabolism on the appearance and extent
of apoptosis. Apoptosis induction could be observed for sam-
ples treated with BSO or BCNU, but the apoptotic window
was shifted to lower ﬂuences, indicating a higher susceptibility
of cells with an impaired GSH system to oxidative stress. The
overall extent of apoptotic cells remained unchanged. Interest-
ingly, the shift of the apoptotic window for the BSO and
BCNU samples was almost identical contrasting the diﬀerent
increase in cytotoxicity following PDT as shown in Fig. 1.
Although BCNU is widely used as a speciﬁc inhibitor of gluta-
thione reductase [22], this observation could be linked to the
multi-functionality of this drug which may alkylate various cel-
lular targets; thus, apart from inhibition of glutathione reduc-
tase another mode of action of BCNU might be involved in
rendering cells more susceptible to induction of apoptosis.
In clear contrast, no apoptotic cells were found in samples
deprived of glucose. This eﬀect is a result of the lack of ATP
in these probes and not of a destruction of enzymes required
for apoptosis (see BSO and BCNU treated samples which
clearly show apoptosis) as it was suggested by a reviewer of
our earlier work [16]. For PDT, at least two studies emphasize
the importance of glycolytic ATP production to compensate
for a reduction of the mitochondrial membrane potential dur-
ing the apoptotic process [16,25] to maintain high ATP levels
after PDT [19]. Taken together, while artiﬁcial inhibition of
the cells pathways to synthesize and regenerate GSH causes
an increased sensitivity towards ROS and an augmented cyto-
toxicity of PDT, it does not interfere with the ability to under-
go active cell death. In contrast, omission of glucose not only
decreases the cells antioxidative capabilities but also abolishes
the energy supply for apoptosis.
Several attempts to inﬂuence the cellular antioxidative sys-
tems have been published where: (i) systemic administration
of BSO augmented photofrin-PDT mediated destruction of
intracerebral 9L gliosarcoma [26], (ii) addition of several low
molecular weight ROS scavengers (e.g., GSH, L-tryptophan
and N-acetyl-L-cysteine) exerted a protective eﬀect against
PDT damage [27,28], and (iii) protection against PDT induced
cell injury was achieved by addition of enzymes involved in the
antioxidative systems (e.g., superoxide dismutase, catalase and
lipoamide dehydrogenase) [27,29]. Additionally, the possibility
of manipulating the cellular antioxidative metabolism by alter-
ation of the concentration or the nature of the carbon source
present in the culture medium was examined recently: substitu-
tion of glucose by galactose results in an increased rate of cell
death induced by hydrogen peroxide [10,12]; an opposite eﬀect
was found for hepatocytes when fructose was added as the ma-
jor carbohydrate in a hypoxia-reoxygenation model [11]. Fur-
ther evidence comes from studies where: (i) addition of
fructose-1,6-bisphosphate protected cortical neurons against
oxidative stress partly by increasing glutathione reductase
activity [30] and (ii) addition of pantothenic acid/pantothenol
(precursors of coenzyme-A) increased net biosynthesis of
GSH by boosting cellular energetics [31]. These studies impres-
sively show a causal relationship between carbohydrate-,
190 T. Kiesslich et al. / FEBS Letters 579 (2005) 185–190energy metabolism and the cells antioxidative competence as
expressed by the glutathione system.
It is important to note that the special case of glucose depri-
vation causes further consequences besides those mentioned
above; among them, alteration of glucose-regulated gene
expression or changes in the ﬂuxes of metabolic pathways
deriving substrates from glycolysis or the Krebs cycle may be
named [32]. However, as demonstrated in this study, changes
in metabolic systems which are instantly aﬀected by glucose
deprivation (such as cellular energetics and the production of
reducing equivalents) and their consequences for the outcome
of PDT in vitro readily can be explained without further need
of taking into account speciﬁc changes in signal transduction
or other more global metabolic regulation.
In conclusion, the novelty of the present study goes back to
the facts that (i) it provides ﬁrst evidence that management of
the in vitro eﬃciency of PDT can be achieved not only by
external administration of components involved in the antiox-
idative defense, but also by manipulation of the carbohydrate
metabolism aiming at the control of the cellular GSH system
and (ii) it also takes into account the possible impact of altered
carbohydrate metabolism on the energetics and, in conse-
quence, the mode of cell death.References
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